~~<i id='6CFDED3E38'><strike id='6CFDED3E38'><tt id='6CFDED3E38'><pre id='6CFDED3E38'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：explore 2025-10-01 23:02:19 - browse：2963

The Roche booth at ESMO in Madrid. — Roche's booth at the 2023 ESMO conference. Andrew Joseph/STAT

MADRID — A Roche drug lowered the risk of recurrence or death by 76% versus chemotherapy for patients with a type of early non-small cell lung cancer, according to data from a Phase 3 trial presented Saturday.

The findings, which Roche is planning to submit to regulators, could give patients with early-stage ALK-positive cancers another option. The standard treatment after surgery for these patients is chemotherapy.

The results from the Alina trial were presented here at the annual meeting of the European Society for Medical Oncology.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Nonprofit, backed by Microsoft, to certify AI tools in health care

hotspot

knowledge

entertainment

Wikipedia

hotspot

focus

CharlesRexArbogast/APRuneLabs,makerofanAppleWatchappthatcantracksymptomsrelatedtoParkinson’sdisease,

WSS

After a drawn out lobbying fight, ARPA

Gene therapy denied for Afghan refugee whose father aided U.S.

FDA early review: GLP

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Inequities make cancer less preventable for women: report

Menendez indictment could see pharma lose a key ally

hotspot

entertainment

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Biogen shutters digital health group, ends Apple study, in cost cutting move

Peter Hotez and the public health issue of online harassment

Merck to acquire Harpoon Therapeutics for $680 million

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Fauci's latest grilling in Congress: 9 hours, behind closed doors

How to save PrEP access — and even expand it

Why do women spend more than men on medical expenses?

knowledge

Paxlovid should be available without a positive Covid test

Gene therapy denied for Afghan refugee whose father aided U.S.

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Health tech startups drop sharply from 2021 highs

Did you have Obamacare on your GOP debate bingo card?

Merck to acquire Harpoon Therapeutics for $680 million

entertainment

Wikipedia

hotspot

focus